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Many Aboriginal conm1unities in rural and remote western 
Australia have rates of chronic suppurative otitis m edia 
(CSOM) 10 times the rate that the World H ealth 
Organization deemed as a massive public health problem in 
the child population. The recognition by Aboriginal lead-
ers that the treatment of CSOM is a priority area has led 
to this issue being highlighted in Australia' s National 
Aboriginal Health Strategy. In Aboriginal children, the dis-
ease usually co11U11ences in infancy within a few weeks of 
birth, causes hearing loss, is recurrent, can persist into adult-
hood, and may impact adversely on child development. 
O ur trial aimed to compare the effectiveness of topi-
cal ciprofloxacin (0.3%) and framycetin (0.5%) , gramicidin, 
dexamethasone (FGD , Sofradex) as treatments for CSOM 
in Aboriginal children. The trial was the first conmmnity-
controll ed, multicenter, double-blind, randomized, con-
trolled trial in Aboriginal children across the north of 
Australia. 
Materials and methods 
One hundred forty-seven children (under 15 years of age) 
were recruited from eight Aboriginal communities. 
Treatments were randomly assigned, and both health work-
ers and parents or guardians were blinded as to treatment. 
Treatment consisted of five drops twice daily for 9 days, and 
ear toilets were administered prior to instillation of eardrops, 
ceasing on clinical cure. Standardized clinical assessments 
were conducted at baseline and at regu lar periods up to 
21 days. The primary outcome was the resolution of otor-
rhea (clinical cure), and secondary outcomes included the 
155 
proportion of children with healed tympanic m embranes 
and improved hearing thresholds. 
Results 
C ure of CSOM was observed in 71 of 111 (FGD, 29/ 56; 
ciprofloxacin, 42/ 55) of the children and was significantly 
greater in the ciprofloxacin group (p = .009), with an ab-
solute difference of24.6% (95% C I 15.8- 33.4%) . No clin-
ically significant difference was fo und in the size of tympanic 
membrane perforation or in the level of hearing impair-
ment when compared before and after treatment . None of 
the persistent bacterial pathogens fo llowing treatment had 
become resistant to ciprofloxacin. 
Conclusions 
Twice-daily ear toilets and topical antibiotics administered 
by both parents and health workers are effective in achiev-
ing cure when administered at the community level. Serious 
consideration needs to be given to increasing the accessi-
bility of twice-daily ciprofloxacin as a first- line option for 
the nonsurgical treatment ofCSOM in Aboriginal children 
in Australia. 1 
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